T. Fujibayashi

发表

Discontinuation of concomitant methotrexate in Japanese patients with rheumatoid arthritis treated with tocilizumab: An interventional study

M. Ando, T. Kojima, N. Takahashi, 2020, Modern rheumatology.

Clinical effectiveness and long-term retention of abatacept in elderly rheumatoid arthritis patients: Results from a multicenter registry system

A. Kaneko, T. Kojima, N. Takahashi, 2018, Modern rheumatology.

Use of a 12-week observational period for predicting low disease activity at 52 weeks in RA patients treated with abatacept: a retrospective observational study based on data from a Japanese multicentre registry study.

A. Kaneko, T. Kojima, N. Takahashi, 2015, Rheumatology.

Longterm Efficacy and Safety of Abatacept in Patients with Rheumatoid Arthritis Treated in Routine Clinical Practice: Effect of Concomitant Methotrexate after 24 Weeks

A. Kaneko, T. Kojima, N. Takahashi, 2015, The Journal of Rheumatology.

Study protocol of a multicenter registry of patients with rheumatoid arthritis starting biologic therapy in Japan: Tsurumai Biologics Communication Registry (TBCR) Study

A. Kaneko, M. Kojima, T. Kojima, 2012, Modern rheumatology.

Association between seropositivity and discontinuation of tumor necrosis factor inhibitors due to ineffectiveness in rheumatoid arthritis

A. Kaneko, T. Kojima, N. Takahashi, 2019, Clinical Rheumatology.

Concomitant methotrexate and tacrolimus augment the clinical response to abatacept in patients with rheumatoid arthritis with a prior history of biological DMARD use

A. Kaneko, T. Kojima, N. Takahashi, 2015, Rheumatology International.

Twenty-four-week clinical results of adalimumab therapy in Japanese patients with rheumatoid arthritis: retrospective analysis for the best use of adalimumab in daily practice

A. Kaneko, T. Kojima, K. Terabe, 2013, Modern rheumatology.

Clinical efficacy of abatacept in Japanese rheumatoid arthritis patients

A. Kaneko, T. Kojima, N. Takahashi, 2013, Modern rheumatology.

Longterm Retention Rate and Risk Factors for Adalimumab Discontinuation Due To Efficacy and Safety in Japanese Patients with Rheumatoid Arthritis: An Observational Cohort Study

A. Kaneko, T. Kojima, N. Takahashi, 2016, The Journal of Rheumatology.

A retrospective analysis of the relationship between anti-cyclic citrullinated peptide antibody and the effectiveness of abatacept in rheumatoid arthritis patients

M. Ando, S. Hirata, A. Kaneko, 2020, Scientific Reports.

Predictors of biologic discontinuation due to insufficient response in patients with rheumatoid arthritis who achieved clinical remission with biologic treatment: A multicenter observational cohort study

A. Kaneko, T. Kojima, N. Takahashi, 2018, Modern rheumatology.

Predictive factors for achieving low disease activity at 52 weeks after switching from tumor necrosis factor inhibitors to abatacept: results from a multicenter observational cohort study of Japanese patients

A. Kaneko, T. Kojima, N. Takahashi, 2015, Clinical Rheumatology.

Longterm Retention Rate and Risk Factor for Discontinuation Due to Insufficient Efficacy and Adverse Events in Japanese Patients with Rheumatoid Arthritis Receiving Etanercept Therapy

A. Kaneko, T. Kojima, N. Takahashi, 2014, The Journal of Rheumatology.

Clinical efficacy of abatacept, tocilizumab, and etanercept in Japanese rheumatoid arthritis patients with inadequate response to anti-TNF monoclonal antibodies

A. Kaneko, T. Kojima, N. Takahashi, 2014, Clinical Rheumatology.

Predictors of disease flare after discontinuation of concomitant methotrexate in Japanese patients with rheumatoid arthritis treated with tocilizumab.

M. Ando, T. Kojima, N. Takahashi, 2020, Joint bone spine.

Right femoral neck pathologic fracture and left femoral subcapital insufficiency fracture in a patient with rheumatoid arthritis

T. Fujibayashi, T. Imamura, 1999 .

Improved safety of biologic therapy for rheumatoid arthritis over the 8-year period since implementation in Japan: long-term results from a multicenter observational cohort study

A. Kaneko, M. Kojima, T. Kojima, 2016, Clinical Rheumatology.

Muscle Damage After Total Hip Arthroplasty Through the Direct Anterior Approach for Developmental Dysplasia of the Hip.

S. Ochiai, Y. Hasegawa, T. Okura, 2017, The Journal of arthroplasty.

Protective effect of geranylgeranylacetone, an inducer of heat shock protein 70, against drug-induced lung injury/fibrosis in an animal model

M. Jijiwa, Y. Hasegawa, T. Kojima, 2009, BMC Pulmonary Medicine.

Clinical efficacy of abatacept compared to adalimumab and tocilizumab in rheumatoid arthritis patients with high disease activity

A. Kaneko, T. Kojima, N. Takahashi, 2013, Clinical Rheumatology.

Concomitant methotrexate has little effect on clinical outcomes of abatacept in rheumatoid arthritis: a propensity score matching analysis

A. Kaneko, T. Kojima, N. Takahashi, 2019, Clinical Rheumatology.

Hemagglutination of preoperative blood donation in patients with rheumatoid arthritis

S. Iwasada, S. Tsuboi, T. Fujibayashi, 2004, Modern rheumatology.

Choice of and response to treatment in patients with early-diagnosed rheumatoid arthritis: Real-world data from an inception cohort in Japan (NICER-J).

H. Ishikawa, H. Wakabayashi, A. Kaneko, 2023, Journal of Orthopaedic Science.

Clinical effectiveness and safety of additional administration of tacrolimus in rheumatoid arthritis patients with an inadequate response to abatacept: A retrospective cohort study

T. Kojima, N. Takahashi, S. Asai, 2019, International journal of rheumatic diseases.

Comparison of efficacy and safety of tacrolimus and methotrexate in combination with abatacept in patients with rheumatoid arthritis; a retrospective observational study in the TBC Registry

A. Kaneko, T. Kojima, N. Takahashi, 2015, Modern rheumatology.

Protective effect of geranylgeranylacetone, an inducer of heat shock protein 70, against drug-induced lung injury/fibrosis in an animal model

M. Jijiwa, Y. Hasegawa, T. Kojima, 2009, BMC Pulmonary Medicine.

Association between seropositivity and discontinuation of tumor necrosis factor inhibitors due to ineffectiveness in rheumatoid arthritis

A. Kaneko, T. Kojima, N. Takahashi, 2019, Clinical Rheumatology.